I always had reservations about the Isity thing. Selling it was going to be the hard test and I don't think they're good salesmen, except when it comes to keeping the s/h's money coming in.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025